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The causative agent of tuberculosis, Mycobacterium tuberculosis, has two chaperonin (Cpn60) proteins and
one cochaperonin (Cpn10) protein. We show here that cpn60.2 and cpn10, but not cpn60.1, are essential for cell
survival. A mutant lacking Cpn60.1 was indistinguishable from the wild-type organism in plate and broth
culture and within murine macrophages, although it showed increased sensitivity to high temperature (55°C).
However, infection of mice with the cpn60.1 mutant revealed a major difference from the wild-type organism.
In spite of having equal numbers of bacteria in infected sites, the cpn60.1 mutant failed to produce granu-
lomatous inflammation in either mice or guinea pigs. This was associated with reduced cytokine expression in
infected animals and macrophages. Cell wall lipid acid composition was not altered in the mutant strain. Thus,
it appears that Cpn60.1 is an important agent in the regulation of the cytokine-dependent granulomatous
response in M. tuberculosis infection.
Chaperonin 60 (Cpn60), also termed heat shock protein 60
(Hsp60), is a prototypical molecular chaperone. Much of our
knowledge about molecular chaperones and their role in pro-
tein folding has emerged from the study of this protein and its
cochaperone, chaperonin 10 (Cpn10). In Escherichia coli, these
oligomeric proteins (the Cpn60 homologue GroEL is a tetra-
decamer and the Cpn10 homologue GroES is a heptamer) are
essential for growth because the GroEL/GroES chaperone sys-
tem is required for the folding of at least 13 essential proteins
(2, 9). Most bacteria have one copy each of the cpn10 and
cpn60 genes in a single operon (13). However, analysis of
genome sequences shows that about 15% of bacteria possess
more than one cpn60 gene. The major human pathogen My-
cobacterium tuberculosis is one such organism. It has been
known for many years that this bacterium produces a potently
immunogenic 60-kDa protein, termed “common antigen” (43),
which was subsequently identified as Hsp65 (or Cpn60.2) (10).
In 1993, a second homologous gene was discovered and named
cpn60.1 (10). The cpn60.1 gene is immediately downstream of
the cpn10 gene in M. tuberculosis, which suggested that it might
encode the major 60-kDa chaperonin of this organism.
Some uncertainly exists about the chaperone functions of
both of the M. tuberculosis Cpn60 proteins because of the
findings that both proteins exist as lower-order oligomers and
not tetradecamers, possess very weak ATPase activity, and are
only weakly active in refolding substrates (27). This biophysical
characterization of both Cpn60 proteins is supported by the
finding that M. tuberculosis Cpn60.2 crystallized as a dimer
(25). This has led to questions being raised about the nature of
the biological functions of these mycobacterial Cpn60 proteins
(26), such as whether these two proteins are required for in-
tracellular protein folding or have a different role, perhaps
associated with cell survival in the various stressful environ-
ments inhabited by M. tuberculosis (26).
The Cpn60.2 (Hsp65) and Cpn10 proteins of M. tuberculosis
are well established as potent immunomodulatory proteins
which have the ability to vaccinate against various rodent mod-
els of human disease (39). This may relate to the finding that
all of the M. tuberculosis chaperonins have the capacity to act
as intercellular signals with human myeloid cells (3, 12, 15, 38)
and vascular endothelial cells (40), causing induction of a
proinflammatory phenotype. M. tuberculosis Cpn60.1 is a more
potent activator of human monocyte cytokine synthesis than is
Cpn60.2 (12). Paradoxically, it has also been reported that
acute administration of M. tuberculosis Cpn60.1 (31) or Myco-
bacterium leprae Cpn60.2 (30), but not M. tuberculosis Cpn60.2
(31), can inhibit experimental allergic asthma in the mouse,
suggesting that these proteins can also act as anti-inflammatory
signals. This raises the question of the role played by any
Cpn60 protein released by mycobacteria.
To determine the roles played by these two Cpn60 proteins,
we attempted to inactivate each cpn60 gene separately, as well
as the cpn10 gene. We demonstrated that it was impossible to
produce M. tuberculosis mutants lacking either the cpn60.2 or
cpn10 gene, suggesting that these genes are both essential for
viability. We successfully generated a cpn60.1 deletion mutant
of M. tuberculosis and examined the characteristics of the mu-
tant in (i) an in vitro model of stationary phase (7) and the
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response to stress, (ii) murine bone marrow-derived macro-
phages and a macrophage-like cell line, and (iii) an immune
resistant model of murine tuberculosis and a guinea pig infec-
tion model (19). We demonstrate an unexpected phenotype of
the cpn60.1 deletion mutant in that it failed to induce a gran-
ulomatous response in the murine experimental model while
showing normal behavior in the other systems.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and plasmids used in
this work are listed in Table 1. M. tuberculosis H37Rv was used as the parental
strain to construct the mutants. M. tuberculosis H37Rv was grown in 7H9 medium
containing 0.05% Tween 80 supplemented with 10% albumin-dextrose complex
(Difco Laboratories) without disturbance. Viability (determined by measuring
CFU) was estimated at the beginning of culture and then at 4- to 10-day intervals
(for up to 100 days) on 7H11 agar medium supplemented with oleic-albumin-
dextrose complex (Difco). Escherichia coli XL1 was used as a host strain for
cloning and plasmid propagation and was grown on Luria-Bertani (LB) medium.
Antibiotics used were as follows: ampicillin (Sigma), 100 g/ml; kanamycin
(Sigma), 20 g/ml; gentamicin (Sigma), 20 g/ml; and hygromycin (Life Tech-
nologies), 100 g/ml.
Mutant construction and complementation. Mutant construction was based
on plasmids p2NIL and pGOAL19 as described previously (20). To construct the
cpn60.1 mutant, a 3,852-bp PCR product containing the cpn60.1 gene and ap-
proximately 1 kb of flanking sequences at each end of the gene was amplified
using M. tuberculosis genomic DNA as the template and primers cpn60.1F (5-
ATTGAATTCGTTCAGCTTCTCCGGGCTC-3) and cpn60.1R (5-ATTGAA
TTCGGACACCACCAACGGATCC-3). The PCR product was cloned into the
HindIII site of pGEM3Z (Promega) to form pYHcpn60.1. An 873-bp MluI
fragment in the cpn60.1 coding region was deleted. The disrupted cpn60.1 gene
was cloned into the HindIII site of p2NIL (20) to make p2NILcpn60.1. To
construct the cpn60.2 mutant, a 3,667-bp PCR product containing the cpn60.2
gene and approximately 1 kb of flanking sequence was amplified using primers
cpn60.2F (5-ATTAAGCTTTGTTGGAGCCGCCAGGGTGA-3) and cpn60.2R
(5-ATTAAGCTTGGCTCCCTGAACAGCGGCAT-3). The PCR product was
cloned into the HindIII site of pGEM3Z (Promega) to form pYHcpn60.2. Two
attempts were carried out to delete the cpn60.2 gene. Firstly, the cpn60.2 gene was
deleted by PCR with primers cpn60.2MF (5-ATTCCATGGGGGTGGCATGGA
TTTCTGAC-3) and cpn60.2MR (5-ATTCCATGGGCGAAGTGATTCCTCCG
GAT-3), which were designed outwardly starting from the start and stop codons of
the cpn60.2 gene, using pYHcpn60.2 as a template. The PCR product, which con-
tained only the flanking sequences of cpn60.2, was cloned into the HindIII site of
p2NIL (20) to make p2NILcpn60.2A. Secondly, a 473-bp NruI fragment which
included 173 bp of upstream sequence from the cpn60.2 start codon was deleted.
The disrupted cpn60.2 gene with flanking sequences was cloned into the HindIII site
of p2NIL to make p2NILcpn60.2B. To construct the cpn10 mutant, a PCR product
of 2,324 bp, including the cpn10 gene and the flanking sequences, was amplified
using primers cpn10F (5-AATAAGCTTATTGTCGCGGCCACCATCG-3) and
cpn10R (5-AATAAGCTTAACGCCTTACGGCGGTCAC-3) and cloned into
pGEN3Z to form pYHcpn10. The cpn10 gene was deleted by PCR with primers
cpn10MF (5-AGCGGCCGCGATTGGAGCCCTCCACTA-3) and cpn10MR (5-
AGCGGCCGCTGGCCGTCGTTTCCAAGT-3), which were oriented outwardly
starting from the start and stop codons of the cpn10 gene, using pYHcpn10 as a
template. The PCR product, containing only two flanking sequences, was cloned into
p2NIL to form p2NILcpn10. A hyg lacZ-sacB marker cassette from pGOAL19 (20)
was cloned into the PacI sites of p2NILcpn60.1, p2NILcpn60.2, and p2NILcpn10 to
form the final mutant constructs p2NIL60.1HS, p2NIL60.2HS, and p2NIL10HS,
respectively. Electroporation of the final constructs into M. tuberculosis H37Rv cells
and the selection of mutants were performed as described previously (21).
To make the complemented strains, a 2,670-bp HindIII fragment from plasmid
pUC-Gm-Int (11), which contains a gene encoding the integrase of phage L5, the
attP site, and a gentamicin resistance marker cassette, was cloned into pGEM3Z
and generated plasmid pYH10. For complementation of cpn60.1, a 2,188-bp
DNA fragment containing the cpn60.1 gene and a 360-bp upstream sequence was
amplified by PCR, using primers cpn60.1CF (5-AATGAATTCTTCTCGTGC
AGGCCAACGA-3) and cpn60.1CR (5-AATGAATTCTGATCGAGGCGTG
CCGATC-3), and then cloned into the EcoRI site of plasmid pYH10 to form
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference or source
Strains
E. coli XL1 recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lacZM15 Tn10 32a
M. tuberculosis strains
H37Rv WT Trudeau mycobacterial
culture collection
YHcpn60.1 M. tuberculosis H37Rv cpn60.1 mutant This work
YHcpn60.1Comp M. tuberculosis H37Rv complemented cpn60.1 mutant This work
YHcpn60.2C M. tuberculosis H37Rv WT with an additional copy of cpn60.2 This work
YHcpn60.2CD cpn60.2 mutation in YHcpn60.2C This work
YHcpn10C M. tuberculosis H37Rv WT with an additional copy of cpn10 This work
YHcpn10CD cpn10 mutation in YHcpn10C This work
Plasmids
pGEM3Z ColE1 replicon; Ampr Promega
p2NIL Mutation vector 20
pGOAL19 hyg PAg85-lacZ Phsp65-sacB pacI cassette vector; Amp
r 20
pUC-GM-int Integrase of phage L5, attP site, and Genr marker cassette 11
pYH10 Insertion of HindIII fragment of pUC-Gm-Int in pGEM3Z This work
pYHcpn60.1 Insertion of cpn60.1 gene in pGEM3Z This work
pYHcpn60.2 Insertion of cpn60.2 gene in PGEM3Z This work
pYHcpn10 Insertion of cpn10 gene in PGEM3Z This work
p2NILcpn60.1 Insertion of disrupted cpn60.1 in p2NIL This work
p2NILcpn60.2A Insertion of disrupted cpn60.2 in p2NIL This work
p2NILcpn60.2B Insertion of NruI-disrupted cpn60.2 in p2NIL This work
p2NILcpn10 Insertion of disrupted cpn10 in p2NIL This work
p2NIL60.1HS Insertion of Hygr gene and sacB in p2NILcpn60.1 This work
p2NIL60.2HS Insertion of Hygr and sacB in p2NILcpn60.2A This work
p2NIL10HS Insertion of Hygr and sacB in p2NILcpn10 This work
pYH10cpn60.1C Insertion of cpn60.1 in pYH10 This work
pYH10cpn60.2C Insertion of cpn60.2 in pYH10 This work
pYH10cpn10 C Insertion of cpn10 in pYH10 This work
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pYH10cpn60.1C. The construct was transformed into the cpn60.1 deletion mu-
tant by electroporation, and gentamicin-resistant transformants were selected.
To introduce an additional copy of the cpn60.2 gene into the wild-type (WT)
strain, a 2,102-bp PCR product, which contained the cpn60.2 gene and a 304-bp
upstream sequence, was amplified using primers cpn60.2CF (5-ATTGAATTC
TTGGCGGTCATGGGCCGAA-3) and cpn60.2CR (5-ATTGAATTCGCTG
CGGTGTCGTACCCATC-3) and then cloned into the EcoRI site of plasmid
pYH10 to form pYH10cpn60.2C. Similarly, to introduce an additional copy of
the cpn10 gene into the WT strain, a PCR product of 706 bp containing the cpn10
gene and 272 bp of upstream sequence was amplified using cpn10CF (5-AAT
GAATTCCGGTGACCCGGACATTGCA-3) and cpn10CR (5-AATGAATT
CGACGCGCGGTTTCGTCGTA-3) and cloned into pYH10 to produce
pYH10cpn10C. After electroporation of the constructs into the WT strain, gen-
tamicin-resistant colonies were selected. All PCR products were sequenced using
both primers to confirm that the sequences matched those expected.
Estimation of cell viability under stress conditions. The M. tuberculosis strains
were grown to late log phase for 10 days. A series of 10-ml cultures were used for
the determination of CFU counts after exposure to environmental stresses. To
induce thermal stress, the cultures were shifted to 55°C for 2 h. To expose cells
to toxic macrophage radicals, cells were incubated with hydrogen peroxide or
diethylenetriamine/nitric oxide adduct (to generate NO) at a final concentration
of 5, 10, or 20 mM. For acidic stress, the culture medium was replaced with acidic
7H9 medium (pH 4). The cultures were then incubated at 37°C. At different
times, CFU counts in the control and stressed cultures were determined. Each
stress experiment was repeated three times.
Infection of bone marrow-derived macrophages. Bone marrow-derived mac-
rophages were prepared as described previously (34). Briefly, bone marrow cells
were flushed from the femurs of female BALB/c mice (6 to 8 weeks old) and
cultured in Dulbecco’s modified Eagle medium (Gibco) supplemented with 10%
fetal bovine serum (Gibco), 20% L cell conditioned medium, 100 U/ml of
penicillin, and 100 g/ml of streptomycin at 37°C in 5% CO2 for 7 days. Adherent
macrophages were harvested and seeded at 106 cells per well in 24-well plates in
the above culture medium without L cell conditioned medium, penicillin, and
streptomycin. For the macrophage cell line J774A.1, the cells were grown to 80%
confluence using the above medium without L cell conditioned medium and
seeded as described above. The bone marrow-derived and J774A.1 macrophage
cells were activated by the addition of gamma interferon (IFN-) (100 U/ml;
R&D Systems) for 24 h, and this was followed by the addition of lipopolysac-
charide (200 ng/ml; Sigma) for 3 h. The cells were infected with M. tuberculosis
H37Rv (WT), the cpn60.1 mutant (YHcpn60.1), and the complemented strain
(YHcpn60.1Comp) at a multiplicity of infection of 1:1 for 4 h. On day 0, 1, 2,
4, or 7 after infection, the cells were washed five times with warm culture medium
and lysed with 0.1% Triton X-100. Various dilutions of the lysed cell suspension
were made, and the numbers of bacteria present were enumerated by counting
CFU. These macrophage infection experiments were repeated three times. On
days 1, 2, and 3 after infection, tumor necrosis factor alpha (TNF-) in the
supernatants of the resting and activated J774A.1 macrophages was analyzed
using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems) accord-
ing to the manufacturer’s instructions.
Mouse infection model. BALB/c mice (Harlan UK Ltd.) weighing 18 to 20 g
were used for the mouse infection model. M. tuberculosis H37Rv WT, mutant,
and complemented strains (2  104 CFU) were injected intravenously into mice.
After 2 h or 1, 2, 3, 6, 12, or 15 weeks after infection, spleens and lungs from
groups of four mice were removed rapidly after sacrifice, and sterile autopsy was
performed. The organs were transferred to 2-ml tubes, with each containing 1 ml
sterile distilled water and 2-mm-diameter glass beads. Lungs and spleens of the
mice were homogenized using a reciprocal shaker (Thermo Hybaid Ltd.) for 40
seconds at speed 6.5. The homogenates were diluted, and CFU counts were
performed. A part of each lung was fixed in 10% buffered formalin, paraffin
embedded, and sectioned for histological examination, which was carried out
commercially by a professional pathologist (Finn Pathologists UK). The mouse
infection experiments were performed twice.
Guinea pig infection. Female Hartley guinea pigs (450 to 500 g) (Harlan UK
Ltd.) were used. The guinea pigs were infected with M. tuberculosis H37Rv WT,
mutant, and complemented strains by intranasal challenge. The animals were
anesthetized with a mixture of halothane and nitrous oxide. Twenty microliters
of M. tuberculosis cell suspension, which contained approximately 104 CFU of
bacilli, was administered into each nostril. After 12 weeks of infection, two
animals in each group were sacrificed. The whole spleen and one of the two lungs
from each animal were removed aseptically for bacteriological examination. The
other lung was fixed in 10% buffered formalin, paraffin embedded, and sectioned
for histological examination.
Cytokine mRNA levels in infected mice. To determine the presence of proin-
flammatory cytokine mRNAs in murine tissues, the right lungs of BALB/c mice
were removed, immediately fixed with RNAlater RNA stabilization reagent
(Qiagen), and kept at 20°C. Thirty milligrams of the fixed lungs was used for
RNA extraction, using an RNeasy mini kit (Qiagen) according to the manufac-
turer’s instructions. RNAs were treated with RNase-free DNase 	 (Qiagen) to
remove contaminating genomic DNA. The sequences of the oligonucleotides for
the cytokines and 
-actin were as follows: for interleukin-6 (IL-6), 5-AGGAG
ACTTCACAGAGGAT-3 (sense) and 5-TCATGTACTCCAGGTAGCT-3
(antisense); for TNF-, 5-CACGCTCTTCTGTCTACTG-3 (sense) and 5-TT
GAAGAGAACCTGGGAGT-3 (antisense); for IFN-, 5-GCTACACACTGC
ATCTTG-3 (sense) and 5-CTGTTGCTGAAGAAGGTAG-3 (antisense); for
IL-12p40, 5-GTAGAGGTGGACTGGACT-3 (sense) and 5-TGGTGCTTCA
CACTTCAG-3 (antisense); and for 
-actin, 5-ATGGATGACGATATCGC
T-3 (sense) and 5-ATGAGGTAGTCTGTCAGGT-3 (antisense). Total RNA
(5 g) was used to synthesize cDNA. The RNA was transcribed in a total volume
of 20 l containing a 0.5 mM concentration (each) of dATP, dCTP, dGTP, and
dTTP, 2.5 M of antisense primer, 5 mM dithiothreitol, 40 units of RNasin
(Promega), 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, and 200 units
of Superscript II (Life Technologies). The reverse transcription (RT) reaction
was carried out at 42°C for 1 h. Ten microliters of diluted cDNA was used for
PCR amplification using the gene-specific primers described above. Each RT-
PCR was repeated twice. The PCR products were separated in a 1% agarose gel,
followed by transfer in 10 SSC buffer (1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate) to a Hybond-N filter (Amersham). The specific probe for each
cytokine was amplified using mouse DNA as a template and the gene-specific
primers described above and then labeled with [-32P]dCTP (specific activity,
3,000 Ci mmol1; ICN) by using the random priming method according to the
instructions of the manufacturer (Amersham). The blots were hybridized with
the specific probes overnight. After being washed, the blots were scanned using
a Storm 840 phosphorimaging instrument at a 50-m pixel resolution. The image
files were analyzed using ImageQuant software (Molecular Dynamics). Quantity
analysis of each PCR was standardized by determining the ratio of the intensity
of the cytokine PCR band to that of the 
-actin band and expressing it as the
relative level of mRNA.
Extraction and analysis of free lipids and mycolic acids. M. tuberculosis
H37Rv WT and the YHcpn60.1 mutant were grown on 7H11 agar medium or
in 7H9 medium (without Tween 80) to mid-log phase (about 10 days). The cells
were harvested by centrifugation, washed with phosphate-buffered saline, and
freeze-dried. The extraction of lipids was performed according to the method
described previously (1). The apolar and polar lipid extracts were resuspended in
chloroform-methanol (2:1), and 50 g of crude lipid was applied to the corners
of 6.6- by 6.6-cm pieces of Merck 5554 aluminum-backed thin-layer chromatog-
raphy (TLC) plates. The plates were developed in a series of solvent systems,
designed to cover the whole range of lipid polarities, as detailed previously (1).
For apolar lipid extracts, these systems were named systems A to D, and for polar
lipid extracts, they were named systems D and E (1). Lipids were visualized using
5% ethanolic molybdophosphoric acid and charring, and glycolipids were visu-
alized by either spraying plates with -naphthol–sulfuric acid followed by gentle
charring of plates or using the Dittmer and Lester reagent, which is specific for
phospholipids and glycophospholipids. Mycolic acid methyl esters were redis-
solved in diethyl ether. After centrifugation, the clear supernatant was again
dried and resuspended in dichloromethane (100 l), and a 50-g aliquot was
subjected to one-dimensional high-performance TLC, using two developments of
hexane-ethyl acetate (95:5). Mycolic acid methyl esters were visualized using 5%
ethanolic molybdophosphoric acid and charring.
Analysis of chaperonin gene transcription in M. tuberculosis H37Rv. For the
analysis of RNA accumulation under stress conditions, a series of 10-ml cultures
of M. tuberculosis H37Rv were used. For heat shock, the cultures were shifted to
45°C for 30 min. For oxidative stress and alcohol shock, H2O2 (10 mM) or
ethanol (5%) was added to the cultures for 30 min. For starvation stress, the
cultures were thoroughly washed with phosphate-buffered saline, resuspended in
10 ml H2O, and then kept at 37°C for 2 h. To induce osmotic stress, the cultures
were exposed to 1.5 M NaCl for 1 h. For acidic and alkaline stress, the culture
medium was replaced with 7H9 medium at pH 4 and pH 10, respectively, for 30
min. RNAs were extracted after exposure to various stresses and analyzed by a
previously constructed M. tuberculosis gridded DNA array (5) containing 82 M.
tuberculosis genes. Each RNA sample was analyzed using three separate arrays.
Array images were scanned using a Storm 840 phosphorimaging instrument at a
50-m pixel resolution. The image files were analyzed using ImageQuant soft-
ware (Molecular Dynamics). The pixel density of each spot was analyzed and
exported to a Microsoft Excel spreadsheet. Background was subtracted by the
software, using the local average background subtraction method. The mean
VOL. 76, 2008 M. TUBERCULOSIS Cpn60.1 IN LOCAL INFLAMMATORY RESPONSE 1537
 o
n
 M
ay 10, 2013 by University of Birm
ingham
http://iai.asm
.org/
D
ow
nloaded from
 
intensity value for each pair of gene spots was divided by the total intensity of all
gene spots in the miniarray and expressed as the percentage of total genes. The
consistency of the percent intensities between duplicate spots on an array was
0.9. Changes in mRNA levels between two different conditions were determined
by comparing the ratio of the mean percentage values of the corresponding gene
spots on the two blots. A threshold value which was equal to the background level
was used to determine the detectable expression of genes in each sample. In-
creases in gene expression are expressed as x-fold induction. Changes in gene
expression, either up-regulation or down-regulation, under different conditions
were considered significant if the changes in the mean percentage values among
different cDNA probes exhibited at least a twofold difference (5). The hybrid-
ization data derived from the triplicate arrays were reproducible (P  0.05;
determined by a paired t test). These experiments were repeated twice with
different preparations of RNA samples.
In vivo complementation of chaperonin genes. The expression vector
pTrc99AgroESL carries the lacIq gene and the trc promoter upstream of the E.
coli groES-groEL operon. DNA fragments containing the M. tuberculosis cpn10,
con60.1, and cpn60.2 genes were amplified by PCR using the following primers:
cpn10F, 5-ATTGAATTCATCGGCTAACCCCTGCGT-3; cpn10R, 5-ATTT
CTAGACGGAAATCACCCGTGGTG-3; 60.1F, 5-AATACTAGTATGAGC
AAGCTGATCGAATAC-3; 60.1R, 5-AATACTAGTGGTGAGCCCTATGG
CGTT-3; 60.2F, 5-ACGACTAGTATGGCCAAGACAATTGCGTA-3; and
60.2R, 5-AATACTAGTCACAAAGGGACCGGGCTC-3. The constructs con-
taining different combinations of the M. tuberculosis chaperonin and groE genes
were made by replacing groES or groEL in pTrc99AgroESL. The constructs were
transformed into E. coli MGM100, in which the groESL operon is expressed
under the control of the pBAD promoter (17). The expression of protein by E.
coli MGM100 harboring each construct was examined by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Viability of strains was deter-
mined at a range of temperatures by CFU counts on LB agar plates in the
presence of glucose (0.5%), which leads to tight repression of the pBAD pro-
moter, with or without IPTG (isopropyl-
-D-thiogalactopyranoside; 0.1 mM) to
induce high expression of the chaperonin genes.
Statistical analysis. The difference between different experimental groups was
determined by a Student t test. P values of 0.05 were considered significant.
RESULTS
Inactivation of chaperonin genes in M. tuberculosis H37Rv.
In order to clarify the function of the chaperonin genes in M.
tuberculosis, a two-step mutagenesis strategy (20) was em-
ployed to disrupt and individually replace the cpn10, cpn60.1,
and cpn60.2 genes. In M. tuberculosis, the cpn60.2 gene is not
adjacent to the cpn10 gene but is located independently in the
genome. In contrast, the cpn10 and cpn60.1 genes are adjacent
in a possible operon with a 95-bp intergenic region (Fig. 1A).
An M. tuberculosis mutant lacking the cpn60.1 gene was
successfully obtained and is referred to as YHcpn60.1.
YHcpn60.1 contains a disrupted cpn60.1 gene which has an
873-bp DNA fragment deleted in its coding region (Fig. 1A).
The presence of the mutation was confirmed by PCR (Fig. 1B)
and Southern blotting analysis (Fig. 1C). Western blotting with
a Cpn60.1-specific antibody confirmed that no Cpn60.1 protein
is produced in this mutant (data not shown).
Despite two attempts to construct both complete and partial
FIG. 1. Construction of M. tuberculosis cpn60.1 mutant. (A) Genomic context of cpn10, cpn60.1, and cpn60.2. The double arrows indicate the
deletions made in these genes. The open boxes a, b, and c show the locations of the fragments used in complementation experiments. (B) PCR
confirmation of the deletion of the cpn60.1 gene, using the primers cpn60.1CF and cpn60.1CR. (C) Southern blotting analysis confirming the deletion
of the M. tuberculosis H37Rv cpn60.1 gene. DNAs from the WT and the YHcpn60.1 strain were digested with NcoI and hybridized with probe b, shown
in panel A. (D) Southern blotting analysis confirming that deletion of the M. tuberculosis H37Rv cpn60.2 or cpn10 gene was possible only when a WT
copy of the gene was present. DNAs from the WT and the YHcpn60.2C strain were digested with AclI and Esp3I and hybridized with probe c, shown
in panel A. Also, DNAs from the WT and the YHcpn10C strain were digested with PvuII and hybridized with probe a, shown in panel A. Since the
WT copy of cpn60.2 or cpn10 was integrated into the chromosomal DNA, digestion with the restriction enzymes resulted in a larger fragment containing
the WT copy of the gene. M, molecular weight marker (Invitrogen). The experiments were repeated twice, with identical results.
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in-frame deletions, neither cpn60.2- nor cpn10-deleted M. tu-
berculosis strains were obtained. To verify that the cpn60.2 and
cpn10 genes are essential in M. tuberculosis, we cloned an
additional copy of cpn60.2 or cpn10 into an integrating vector
and introduced this plasmid into the WT strain, which allowed
the copy of the gene to integrate into the M. tuberculosis
chromosome. Deletion of the chromosomal copy of the
cpn60.2 or cpn10 gene in the presence of the insertion copy was
now able to be achieved (Fig. 1D), and we termed the strains
YHcpn60.2C and YHcpn10C, respectively. This strongly
suggests that cpn60.2 and cpn10 are essential genes for M.
tuberculosis.
To complement cpn60.1 in YHcpn60.1, the plasmid
pYH10cpn60.1C, which contains the cpn60.1 coding region
and a 360-bp upstream sequence of the gene, was transformed
into YHcpn60.1, followed by selection for gentamicin resis-
tance. The complemented strain was confirmed by PCR (data
not shown) and is referred to as YHcpn60.1Comp.
In vitro growth and survival of YHcpn60.1 under stress
conditions. The WT, YHcpn60.1, and YHcpn60.1Comp
strains were grown in 7H9 broth without disturbance for 100
days. At various times, samples were taken to assess CFU.
Similar growth curves were obtained for both the WT and the
mutant (data not shown), suggesting that the absence of the
cpn60.1 gene had no significant effect on the growth of M. tuber-
culosis H37Rv in vitro. In order to determine if cpn60.1 plays any
role in the response of M. tuberculosis to stress, we examined the
survival of the WT, YHcpn60.1, and YHcpn60.1Comp strains
under various stress conditions. The only major difference be-
tween the strains was that exposure to a temperature of 55°C
killed YHcpn60.1 more rapidly than the WT. The CFU of
YHcpn60.1 decreased fourfold more than the WT at 20 min,
and sixfold more killing of the mutant was seen at 2 h (P 0.001).
The parental level of heat sensitivity was restored in the
YHcpn60.1Comp strain (Fig. 2). Thus, the loss of the cpn60.1
gene rendered the strain more sensitive to high temperature. In
contrast, no significant differences were observed between the
WT and YHcpn60.1 strains upon treatment with H2O2 and NO
and growth at pH 4 (data not shown), mimicking the stress
conditions M. tuberculosis is most likely to encounter during
infection.
Cell wall lipid analysis. A previous study demonstrated that
inactivation of cpn60.1 in Mycobacterium smegmatis results in
alterations in mycolic acid biosynthesis and changes in biofilm
formation (18). To determine if there were changes in cell wall
composition in the equivalent M. tuberculosis mutant, we ex-
amined the lipids and mycolic acids of the WT and the
YHcpn60.1 mutant grown on 7H11 agar plates or in 7H9
broth, using TLC. In the previous study, the lipid and mycolic
acid analysis of M. smegmatis biofilms used cells which were
grown on M63 salts minimal medium (18). We attempted to
grow M. tuberculosis H37Rv on the same medium, but the
bacilli grew poorly and no biofilms were formed. We then grew
the bacterium on 7H11 agar medium. No differences were
observed in nonpolar lipid, polar lipid, or mycolic acid com-
position between the WT strain and the YHcpn60.1 mutant
grown on 7H11 agar plates (data not shown). We also grew the
WT and the mutant in 7H9 medium without Tween 80, in
which the bacilli formed clumps and surface pellicles. Again,
no differences were found in lipid and mycolic acid composi-
tion (data not shown). The lipid profiles of the WT and the
mutant were the same under all growth conditions we tested
(data not shown).
Growth and survival of YHcpn60.1 in macrophages. In
order to investigate the ability of YHcpn60.1 to replicate and
persist inside macrophages, resting and activated murine bone
marrow-derived macrophages and a macrophage-like cell line,
J774A, were infected with log-phase cultures of the WT,
YHcpn60.1, and YHcpn60.1Comp strains. No significant dif-
ferences were found between the cell numbers of each strain
recovered from either resting or activated bone marrow-de-
rived macrophages (Fig. 3). Similar results were observed with
the J774A.1 cell line (data not shown).
Growth and persistence of YHcpn60.1 in immunocompe-
tent mice. To determine whether the deletion of the cpn60.1
gene affected growth and persistence in vivo, a mouse model in
which M. tuberculosis persists in the animals for the duration of
the experiment was used (19). In this model, a low dose of M.
tuberculosis is used to infect immunocompetent mice. M. tu-
berculosis exhibits log-phase growth initially. After 2 to 3 weeks
of infection, the mice develop an acquired immune response
which restricts growth of the bacteria. Using this model, we can
distinguish the ability of the WT and the YHcpn60.1 mutant
to grow and survive in the face of host innate and adaptive
immunity. The WT, YHcpn60.1, and YHcpn60.1Comp
strains were injected intravenously, with each mouse being
given 3  104 CFU of bacteria. The viability of the injected
organisms was determined by taking samples from mice, re-
covering bacteria, and counting CFU for the 15-week duration
of the experiment. In the lungs, there was an initial lower
growth rate of YHcpn60.1, showing 0.5, 0.33, 0.33, and 0.5 log
fewer cells in the lungs at 1, 2, 3, and 6 weeks, respectively, but
by 12 weeks there was no significant difference between the
mutant and the WT cells (Fig. 4A). In the spleen, the growth
of YHcpn60.1 was attenuated for the first 3 weeks of infec-
tion and then reached the same level as the WT (Fig. 4B).
FIG. 2. Inactivation of cpn60.1 renders cells more susceptible to
elevated temperature. The graph shows a time course of survival for
WT cells () compared with YHcpn60.1 (f) and YHcpn60.1Comp
(Œ) cells at 55°C. The data shown are averages for three independent
experiments  standard errors. Statistical significance was determined
by Student’s t test (n  3) (**, P  0.01; ***, P  0.001).
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Parental levels of growth and survival were seen in
YHcpn60.1Comp.
Lung pathology in infected mice. Histopathological exam-
ination of the lungs from BALB/c mice infected with the WT
and the mutant was performed at 3, 6, and 15 weeks of
infection. No significant difference was observed in both
WT- and mutant-infected lungs at 3 weeks of infection (Fig.
5A and B), despite the fact that the CFU counts in the WT
strain-infected lungs were about 0.33 log higher than those
in the mutant-infected lungs. In animals killed after 6 weeks
of infection, the lungs infected with the WT strain had
moderate to marked diffuse increases in cellularity of the
alveolar walls, showing several substantial focal accumula-
tions of mixed inflammatory cells as well as occasional mod-
erate aggregation of alveolar macrophages (Fig. 5D). At 15
weeks of infection, the lungs infected with the WT organism
showed large areas of granulomatous inflammation (encom-
passing approximately 50% of the total lung area), with
changes consistent with early granuloma formation (Fig.
5G). In complete contrast, in animals infected with
YHcpn60.1, the infected lungs showed only slight increases
in the numbers of inflammatory cells in the alveolar walls,
with normal alveoli and airways evident throughout the
lungs (Fig. 5E and H). This indicated that the mutant failed
to cause classical tubercular disease. Normal granulomatous
inflammation was observed in mouse lungs infected with the
complemented strain (Fig. 5F and I). The histopathological
examination was performed using three mice per group, and
three slides were examined for each lung. The experiment
was repeated, with identical results. Representative histol-
ogy of the mouse lung for each group is shown.
In order to further confirm that the lack of granulomas
in mouse lungs was due to the deletion of the cpn60.1 gene,
we infected guinea pigs with the WT, YHcpn60.1, and
YHcpn60.1Comp strains via the nostril route. As shown in Fig.
5J, after 12 weeks of infection, the lungs infected with the WT
strain had large numbers of inflammatory cells, including mac-
rophages, lymphocytes, and granulocytes. In contrast, the
YHcpn60.1-infected lungs (Fig. 5K) were largely normal,
with only a slight increase of cellularity of alveolar walls. The
same level of granulomatous inflammation as that for the
WT strain was seen in the lungs infected by the comple-
mented strain (Fig. 5L). CFU counts in the organs were 3.75
log CFU/spleen and 4.58 log CFU/lung for mice infected with
the WT strain, 3.76 log CFU/spleen and 4.51 log CFU/lung for
mice infected with the YHcpn60.1 strain, and 3.73 log CFU/
FIG. 3. Growth and survival of M. tuberculosis cpn60.1 in resting and
IFN--activated macrophages. (A) Infection in resting bone marrow-de-
rived macrophages. (B) Infection in IFN--activated bone marrow-de-
rived macrophages. , H37Rv WT; f, YHcpn60.1; Œ, YHcpn60.1
Comp. These results are the means and standard deviations derived
from three independent experiments carried out in triplicate.
FIG. 4. Growth of WT and YHcpn60.1 in the lungs and spleens of
mice. Mice were infected with 3  104 bacteria, and at various times
over a 15-week period, groups of mice were sacrificed and the numbers
of bacteria in the lung (A) or spleen (B) were measured. The numbers
of WT (), isogenic mutant (f), and complemented mutant (Œ) cells
in these two tissues were not significantly different at the last two time
points measured. The experiments were repeated twice, with similar
CFU counts for lungs and spleens.
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spleen and 4.57 log CFU/lung for mice infected with the
YHcpn60.1Comp strain.
RT-PCR analysis of mouse cytokine expression in WT- and
cpn60.1 mutant-infected mouse lungs. To investigate if the
lack of granuloma formation in mice was a result of changes in
the host immune response, we monitored the mRNA levels of
TNF-, IFN-, IL-6, and IL-12 in lungs infected with the WT
or the YHcpn60.1 mutant, using semiquantitative RT-PCR.
The levels of all cytokine mRNAs were significantly lower in
the lungs infected with YHcpn60.1. There was a 1.5- to 3.5-
fold reduction of these cytokines at 2, 3, and 15 weeks of
infection (P  0.05) (Fig. 6). The mRNA levels in uninfected
mouse lungs were indistinguishable from the background and
thus were treated as zero. We also examined cytokine expres-
sion in a macrophage-like cell line. After infection with the WT
or the mutant, similar expression levels of TNF-, IL-6, IL-12,
and IL-10 were observed (data not shown).
ELISA analysis of TNF- levels in WT- and mutant-infected
macrophages. To further confirm that the mutant lacking the
cpn60.1 gene fails to induce the same levels of cytokines in the
host as the WT, we measured the TNF- levels in infected
J774A.1 macrophages. Similar to the cytokine mRNA levels
FIG. 5. Lung histology in mice and guinea pigs infected with the WT, YHcpn60.1, and complemented strains. Hematoxylin- and eosin-stained
sections (magnification, 10) show mouse lungs infected with the WT (A), YHcpn60.1 (B), and YHcpn60.1Comp (C) strains for 3 weeks; mouse
lungs infected with the WT (D), YHcpn60.1 (E), and YHcpn60.1Comp (F) strains for 6 weeks; and mouse lungs infected with the WT (G),
YHcpn60.1 (H), and YHcpn60.1Comp (I) strains for 15 weeks. Histopathological examination was performed using three mice in each group.
Three sections from each mouse were examined. The data shown are representative of lung sections from three animals in each experimental
group. Guinea pig lungs infected with the WT (J), YHcpn60.1 (K), and YHcpn60.1Comp (L) strains for 12 weeks are also shown. Two guinea
pigs in each group were used for histopathological examination.
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observed in the infected mice, the TNF- levels of the
cpn60.1 mutant-infected macrophages were significantly re-
duced on days 1, 2, and 3 of infection in both resting and
activated macrophages (Fig. 7). The TNF- level was recov-
ered in the macrophages infected with the complemented
strain. The CFU counts of the mutant, the WT, and the com-
plemented strain at those time points when the cytokines were
measured were the same, indicating that the cpn60.1 mutant
retained the ability to invade and survive in macrophages but
stimulated significantly lower levels of TNF-.
In vivo complementation of E. coli groEL and groES by M.
tuberculosis genes. In order to investigate whether M. tubercu-
losis cpn gene products can function as molecular chaperones,
an E. coli in vivo complementation system was used. In this
model, the chromosomal groE promoter has been replaced by
the pBAD promoter from the arabinose operon, which means
that synthesis of native GroEL and GroES is completely re-
pressed by the presence of glucose but can be induced in the
presence of arabinose. This allows the ability of heterologous
or mutant chaperonins to chaperone the folding of GroEL-
dependent proteins in vivo to be determined (36). Constructs
expressing the M. tuberculosis chaperonin proteins from the
strong trc promoter were transformed into E. coli MGM100 to
examine if they supported cell growth and therefore func-
tioned as molecular chaperones. As shown in Fig. 8A, Cpn60.2
coexpressed with either Cpn10 or GroES was able to support
normal E. coli growth at 37°C, although cpn60.2 plus cpn10
complemented growth only in the present of IPTG. cpn60.2
plus groES always showed good complementation with and
without IPTG. This may be due to a combination of leaky
expression and differences in the efficiency of translation of
Cpn60.2 depending on the precise sequence of the DNA im-
mediately upstream of it. Interestingly, the molecular mass of
Cpn60.2 measured by SDS-PAGE differed slightly depending
on whether it was coexpressed with Cpn10 or with GroES (Fig.
8B). The reason for this difference is not clear, but N-terminal
sequence and mass spectrometry analysis showed that it was
not due to N-terminal cleavage (data not shown). Cpn60.1 was
expressed at reasonable levels with GroES but failed to com-
plement E. coli MGM100 at any temperature tested. When it
was expressed with Cpn10, expression was extremely poor and
it could only be seen on Western blots (data not shown);
complementation also did not occur in this case. These results
clearly show that Cpn60.2 and Cpn10 can function as molec-
ular chaperones in E. coli but that Cpn60.1 cannot, at least
under the conditions of this assay.
Effect of stress on chaperonin mRNA levels. In order to
determine how cpn60.1, cpn60.2, and cpn10 were expressed
under stress conditions, we examined the mRNA levels of
these genes in the WT strain by using a previously described
mini DNA array containing 82 M. tuberculosis genes (5). The
M. tuberculosis H37Rv cultures were exposed to a variety of
stress conditions, including elevated temperature, increased
osmolarity, low and high pH, starvation, and hydrogen perox-
ide. Among the 82 genes, mRNA levels were significantly in-
creased for about 30 genes, including those which were previ-
FIG. 6. Cytokine mRNA expression in the lungs of mice infected with either M. tuberculosis WT or YHcpn60.1. RNAs were extracted from
the lungs of mice infected with the WT or YHcpn60.1 for 2, 3, and 15 weeks and subject to semiquantitative RT-PCR. The intensities of the PCR
bands were normalized with those of 
-actin. The mRNA level at each time point was examined using groups of three mice. Open bars,
WT-infected lungs; filled bars, YHcpn60.1 mutant-infected lungs. The values are the means for three RT-PCR analyses of RNAs extracted from
three mice, and the results were confirmed in one independent repeat experiment. Statistical significance was determined by Student’s t test (*,
P  0.05; **, P  0.01; and ***, P  0.001).
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ously described to be induced under stress conditions, for
example, katG (16), which was increased about 10-fold after
exposure to H2O2; and sigB (6) and sigE (14), which were
increased in response to heat shock, H2O2, ethanol, starvation,
and hyperosmolarity (data not shown). As shown in Fig. 9,
cpn10 showed marked increases in intracellular mRNA levels.
mRNA levels of cpn60.2 increased significantly apart from the
case under acidic conditions. In contrast, the expression of
cpn60.1 showed significant increases only under stress condi-
tions such as elevated temperature and hyperosmolarity (Fig.
9). The cpn10 gene rarely had a similar pattern of expression to
cpn60.1, but its expression in response to heat shock, pH 10,
and starvation was consistent with that of cpn60.2 (P  0.1,
P  0.5, and P  0.05, respectively). The primers which were
used to synthesize cpn60.1 and cpn60.2 cDNAs (radioactivity-
labeled probes) were designed within the conserved sequence
of each gene in order to avoid cross-hybridization between
these two genes.
DISCUSSION
We have taken several approaches to clarify the biological
functions of the M. tuberculosis Cpn60 chaperonins. We at-
tempted to inactivate the individual cpn60.1, cpn60.2, and
cpn10 genes. It proved impossible to inactivate cpn60.2 or
cpn10 unless additional copies of these genes were present on
the chromosome. In contrast, it was possible to inactivate the
cpn60.1 gene. Thus, Cpn60.2 has an essential role in M. tuber-
culosis for which Cpn60.1 cannot substitute, at least at its
normal levels of expression. This confirms the previous finding
that M. smegmatis cpn60.2 is an essential gene whose product
functions as a housekeeping molecular chaperone (18). Our
results also confirm and extend an earlier study using global
transposon mutagenesis which suggested that both the cpn60.2
and cpn10 genes were required by M. tuberculosis for optimal
growth and that cpn60.1 was a nonessential gene (33). It is
interesting that although cpn10 and cpn60.1 are adjacent in the
chromosome, their expression profiles under some stress con-
ditions are distinctively different, which suggests that these two
genes are differentially regulated. Previous work demonstrated
that cpn60.1 might not be cotranscribed with cpn10 (10), as
these two genes contain independent transcriptional start sites.
However, in spite of their separate locations in the genome,
cpn10 and cpn60.2 share similar patterns of expression and are
both required for M. tuberculosis to grow and survive. This
FIG. 8. (A) Cultures of MGM100 expressing different combina-
tions of chaperonin proteins were grown overnight in arabinose, seri-
ally diluted in LB, and spotted onto plates containing 0.2% glucose and
0.1 mM IPTG. The strains contained the following plasmids: 1, ptrc-
groES-cpn60.1; 2, ptrc-groES-cpn60.2; 3, ptrc-cpn10-cpn60.1; 4, ptrc-
cpn10-cpn60.2; 5, ptrc99A (vector only); and 6, ptrc-groES-groEL.
(B) 8% SDS-PAGE gel with proteins expressed by the strains in panel
A, loaded in the same order. Lane M contains molecular weight mark-
ers. These experiments were repeated twice, with similar results.
FIG. 7. TNF- levels in J774A.1 macrophages infected with the M.
tuberculosis WT, YHcpn60.1, and complemented strains, determined
by ELISA. TNF- levels were measured in both resting macrophages
and IFN--activated macrophages. The data shown are the averages
for two independent experiments  standard errors. Statistical signif-
icance was determined by Student’s t test (n  2) (*, P  0.05; **,
P  0.01; and ***, P  0.001).
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indicates that these two genes are under similar mechanisms of
regulation and is consistent with the two proteins acting to-
gether, as would be predicted from the E. coli chaperonin
system.
Inactivation of cpn60.1 had few consequences other than
increased susceptibility to high temperature (55°C), which sug-
gests that cpn60.1 has a role in thermotolerance in M. tuber-
culosis. It is interesting that the loss of thermotolerance in the
cpn60.1 mutant was seen during the first 20 to 40 min of heat
shock, when killing of the mutant was about 1 log greater than
that of the WT strain, but thereafter the two survival curves
became more or less parallel. This suggests that an alternative
chaperoning activity may be induced by heat shock, compen-
sating for the loss of Cpn60.1 at later time points. The
YHcpn60.1 mutant was equivalent to the WT when exposed
to pathophysiological stresses, such as H2O2, NO, and low pH,
which would be encountered when bacteria come into contact
with host leukocytes. The loss of the cpn60.1 gene did not
inhibit the ability of M. tuberculosis to survive and grow within
resting or activated macrophages, supporting the previous
findings.
We demonstrated that YHcpn60.1 grew slightly slower
than the WT strain or YHcpn60.1Comp in the mouse lung and
spleen in early infection, but by 12 weeks the numbers of
organisms in these tissues were equivalent. It is not known why
the mutant shows slower growth in the first few weeks of
infection yet continues to grow after the onset of the acquired
immune response and then reaches a plateau 12 weeks after
infection. This continued growth could be due to a reduced
immune response, and indeed, this was seen during the course
of infection in mutant-infected mice (Fig. 6). At the early stage
of infection (1 to 3 weeks), the difference in CFU counts per
organ (0.3- to 0.5-log difference) led to no significant difference
in the inflammation of the lungs infected by both the WT and
the mutant, with both showing moderate, diffuse increases in
cellularity of the alveolar walls containing inflammatory cells.
It was surprising, therefore, to find that the lungs of mice
infected with the isogenic mutant showed much less evidence
of inflammation than did those of mice infected with the WT
at 15 weeks of infection, 3 weeks after the CFU counts reached
the same level as that of the WT strain. The mutant lacked the
ability to stimulate granulomatous inflammation. Further-
more, the spleen size in mice infected with YHcpn60.1 was
smaller than that in mice infected with the WT (data not
shown), again showing that the mutant is less inflammatory.
This lack of granulomatous formation was confirmed in guinea
pigs, using an aerosol infection model via nostril administra-
tion. As an independent measure of inflammation, the mRNA
levels of various key proinflammatory cytokines (IFN-,
TNF-, IL-6, and IL-12) in the lungs of mice were measured
and shown to be lower in the animals infected with YHcpn60.
The reduced cytokine production caused by the cpn60.1 mu-
tant was also confirmed in macrophages analyzed by ELISA.
These results indicated that the reduced pathology caused
by this mutant may be due to failure of the strain to stimulate
T-helper 1-type immunity, which is the major contributor to
controlling M. tuberculosis disease progress (28). It is not un-
common for a loss of one protein in M. tuberculosis to result in
reduced tuberculous disease. Work in other laboratories dem-
onstrated that an M. tuberculosis strain lacking whiB3 failed to
cause granulomatous inflammation in mice, despite the CFU
counts of the whiB3 mutant and the WT being similar in
animal organs during the course of infection (35). WhiB3 may
play a role as a transcriptional regulator which controls genes
involved in stimulation of the host immune response. Another
example is an M. tuberculosis mutant containing a disrupted
sigH gene, which grows and survives in mice but produces a
reduced inflammatory pathology in mice (8). As an M. tuber-
culosis sigma factor, sigH regulates the transcription of many
genes, any of which could be responsible for the reduction of
immunopathology (8). The mechanisms by which the cpn60.1
gene operates to regulate the virulence of the bacterium are
unknown. Hatfull et al. recently reported that inactivation of
the cpn60.1 gene in M. smegmatis results in an alteration in
biofilm formation and suggested that this might be relevant to
the virulence of M. tuberculosis (18). The proposed mechanism
is that Cpn60.1 associates with the 3-oxoacyl (acyl carrier pro-
tein) synthase proteins, KasA and KasB, involved in mycolic
acid synthesis (18). These are not among the proteins that
interact with GroEL in E. coli. We looked for alterations in cell
wall lipid composition in our WT and YHcpn60.1 mutant. We
grew the bacilli on 7H11 agar or in 7H9 medium without
Tween but failed to see any differences between the WT and
mutant strains. This discrepancy may due to the fact that the
growth of the bacilli which we prepared on agar plates or in
7H9 medium was not the same as that described in the M.
smegmatis study. We attempted to grow M. tuberculosis H37Rv
strains in M. smegmatis biofilm medium (18), but the bacilli
failed to grow and form biofilms, indicating that either M.
tuberculosis does not form biofilms or the conditions that pro-
mote changes in lipids similar to those in M. smegmatis have yet
to be identified. Of course, M. smegmatis is a very distinct
organism from M. tuberculosis (41). For example, M. smegmatis
is not a pathogen. Also, it contains three cpn60 genes. Analysis
of a transposon mutant library of Mycobacterium avium re-
vealed a number of genes (not including cpn60.1) that impair
FIG. 9. Cellular levels of mRNAs for M. tuberculosis Cpn60.1,
Cpn60.2, and Cpn10 proteins under stress conditions. M. tuberculosis
in culture was exposed to a variety of physical, chemical, and biological
stressors, and the mRNA levels of cpn10, cpn60.1, and cpn60.2 were
determined. The results are the means for three independent experi-
ments  standard errors. In each experiment, RNAs from one single
extraction were examined by triplicate array analysis.
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biofilm formation (42). The virtually identical Cpn60.2 pro-
teins from M. tuberculosis and M. leprae have very different
anti-inflammatory actions in mice (30, 31), and in general,
different Cpn60 proteins exhibit a bewildering variety of activ-
ities (4, 32). Given these findings, it is not surprising that M.
tuberculosis Cpn60.1 does not behave identically to the M.
smegmatis homologue. It will be intriguing to discover whether
Cpn60.1 from M. tuberculosis can complement the cpn60.1
defect in M. smegmatis, and such experiments are currently in
progress.
We have shown here that M. tuberculosis Cpn60.2 can, in
concert with Cpn10 or GroES, restore viability of the
MGM100 strain when it is grown in glucose to switch off the
endogenous groES/groEL operon. Cpn60.2 combined with
Cpn10 or GroES can therefore fold at least some of what have
been termed class III proteins in E. coli (9). These are 84
low-abundance proteins in E. coli that are thought to have the
common characteristic of the persistence of exposed hydro-
phobic regions during the folding process and which require
the GroEL and GroES proteins in order to fold. They include
13 essential E. coli proteins, thus accounting for the indispens-
able nature of the chaperonin system (9). This result shows
that despite the lower stability of the Cpn60.2 complex com-
pared to that of GroEL (27), Cpn60.2 is highly likely to func-
tion as a tetradecamer in vivo, since it can interact with the
heptameric E. coli GroES complex. Cpn60.1, however, was
unable to complement for the loss of GroEL, even when it was
expressed to levels where Cpn60.2 did complement, implying
that this protein cannot function as a molecular chaperone in
E. coli. Cpn60.1 may bind a different substrate or substrates
from those of GroEL and Cpn60.2 or may have some other
function altogether in the cell. Current experiments are testing
these possibilities.
The chronic granulomatous pathology of tuberculosis is
driven, in an as yet undiscovered manner, by M. tuberculosis,
and the overproduction of host proinflammatory cytokines,
such as TNF-, plays a key role. There are now a number of
reports that bacterial Cpn60 proteins, including those from M.
tuberculosis, can stimulate human monocytes to secrete proin-
flammatory cytokines (3, 12, 22–24, 29, 37). It is interesting
that in spite of 70% sequence identity, the Cpn60.1 protein of
M. tuberculosis is both more potent and more efficacious than
the Cpn60.2 protein and appears to activate myeloid cells
through a different receptor (12). The simplest explanation is
that it is the absence of the proinflammatory activity of the
Cpn60.1 protein that accounts for the failure of the cpn60.1
mutant to induce granulomatous inflammation.
In conclusion, our results show that Cpn60.1 is a nonessen-
tial molecular chaperone with minimal cell stress protein ac-
tivity. It plays an important role in stimulating proinflamma-
tory cytokine production, which is essential for tuberculosis
disease manifestation.
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